Quantitative evaluation of myocardial fibrosis by cardiac integrated backscatter analysis in Kawasaki disease

Lijian Xie1, Renjian Wang2, Min Huang2

  • 1Department of Cardiology, Shanghai Children's Hospital, Shanghai Jiaotong University, No. 355 Luding Road, Shanghai, 200062, China. naijileix@aliyun.com.

Cardiovascular Ultrasound
|January 13, 2016
PubMed

Insights

Myocardial fibrosis is present in Kawasaki disease (KD) patients, even in early stages. Cardiac integrated backscatter imaging quantifies this fibrosis, which correlates with coronary artery status in KD.

Area of Science:

  • Cardiology
  • Pediatric Rheumatology
  • Medical Imaging

Background:

  • Kawasaki disease (KD) is an acute systemic vasculitis affecting coronary arteries.
  • The presence and extent of myocardial fibrosis in KD have not been previously quantified.
  • This study investigates myocardial fibrosis in KD patients using cardiac integrated backscatter (CIB).

Purpose of the Study:

  • To quantitatively assess myocardial fibrosis in Han Chinese patients with Kawasaki disease.
  • To explore the relationship between myocardial fibrosis and the coronary artery status in KD patients.
  • To evaluate the utility of cardiac integrated backscatter (CIB) imaging for detecting myocardial fibrosis in KD.

Main Methods:

  • Ninety KD patients and 90 healthy controls were enrolled.
  • KD patients were categorized by disease phase (acute, subacute, convalescence) and coronary artery status (none, dilation, aneurysms).
  • Myocardial fibrosis was assessed using calibrated integrated backscatter (CIBS) imaging via echocardiography.

Main Results:

  • Left ventricular systolic function was normal in all participants.
  • CIBS values, indicating myocardial fibrosis, were significantly elevated in all KD phases compared to controls (p < 0.001).
  • Higher CIBS values correlated with more severe coronary artery lesions (dilation, aneurysms) and were positively correlated with coronary artery status across all KD phases (r = 0.331–0.456, p < 0.001).

Conclusions:

  • Myocardial fibrosis is detectable and quantifiable in Kawasaki disease patients, even in early stages.
  • The degree of myocardial fibrosis correlates with the severity of coronary artery involvement in KD.
  • Cardiac integrated backscatter imaging is a valuable tool for assessing myocardial fibrosis in Kawasaki disease.
Abstract